Singapore - engelsk - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - sodium citrate 4% solution is intended for regional anticoagulation in continuous renal replacement therapies (crrt) in adults: - continuous veno-venous haemodialysis (ci-ca® cvvhd) - post-dilution continuous veno-venous haemodiafiltration (ci-ca® post cvvhdf) sodium citrate 4% solution must only be used with fresenius medical care crrt devices multifiltrate and multifiltratepro for the mentioned blood processing therapies, and having integrated pumps to administer citrate and calcium.

Singapore - engelsk - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - bloodlines are intended for single use only for extracorporeal blood purifications for human use.

Singapore - engelsk - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - gastroenterology & urology - fresenius multifiltrate kit is for continuous renal replacement therapy. ultraflux av 600s and av1000s are designed for single use in acute dialysis with machine assisted continuous veno-venous haemofiltration, haemodialysis and haemodiafiltration (cvvh, cvvhd, cvvhdf). av600s is also suitable for a non-machine assisted continuous arterio-venous haemofiltration or haemodialysis (cavh, cavhd). av1000s is specifically recommended for high volume cvvh/cvvhdf. ultraflux emic2 are designed for single use in acute dialysis with machine assisted continuous veno-venous haemodialysis (cvvhd) as well as for the sledd- therapy (slow extended daily dialysis). blood line/ tubing systems (cassette multifiltrate, cassette cica multifiltrate, dialysate system multifiltrate) are intended for single use only for extracorporeal blood purification.

Singapore - engelsk - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - intended for performing chronic and acute hemodialysis. it can be used in home dialysis, hemodialysis and limited care centres and clinical hemodialysis.

Singapore - engelsk - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - gastroenterology & urology - fresenius multifiltrate kit 5 pre post cvvh 600 is for continuous renal replacement therapy . ultraflux av 600s are designed for single use in acute dialysis with machine assisted continuous veno-venous haemofiltration, haemodialysis and haemodiafiltration (cvvh, cvvhd, cvvhdf). it is also suitable for a non-machine assisted conditions arterio-venous haemofiltration or haemodialysis (cavh, cavhd). multifiltrate cassette and dialysate hv-cvvh substituate set are intended for single use only for extracorporeal blood purification. for use with multifiltrate acute dialysis machines.

Singapore - engelsk - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - intended for performing chronic and acute hemodialysis. it can be used in home dialysis, hemodialysis and limited care centres and clinical hemodialysis.

Singapore - engelsk - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - intended for performing chronic and acute hemodialysis. it can be used in home dialysis, hemodialysis and limited care centres and clinical hemodialysis.

Singapore - engelsk - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - it is intended for single use only for extracorporeal blood purifications.

Singapore - engelsk - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - they are single use medical devices for use in peritoneal dialysis.

Singapore - engelsk - HSA (Health Sciences Authority)

fresenius medical care singapore pte. ltd. - general hospital - the bcm - body composition monitor assists the physician in assessing the hydration status by a bioimpedance spectroscopy measurement of the body composition from which the level of overhydration can be derived. apart from the hydration status, the device also determines the patient's nutritional condition. the device permits continuous monitoring of the body composition and provides an objective indicator for the nutritional condition: the lti (lean tissue index) and the fti (fat tissue index). the bcm - body composition monitor also determines of the urea distribution volume to calculate the dialysis dose (kt/v). the bcm - body composition monitor is intended for screening and monitoring of patients with renal diseases within the scope of dialysis therapy and extracorporeal therapies. it can be used in dialysis centers, hospitals, medical practices.